1. Home
  2. XENE vs HP Comparison

XENE vs HP Comparison

Compare XENE & HP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XENE
  • HP
  • Stock Information
  • Founded
  • XENE 1996
  • HP 1920
  • Country
  • XENE Canada
  • HP United States
  • Employees
  • XENE N/A
  • HP N/A
  • Industry
  • XENE Biotechnology: Pharmaceutical Preparations
  • HP Oil & Gas Production
  • Sector
  • XENE Health Care
  • HP Energy
  • Exchange
  • XENE Nasdaq
  • HP Nasdaq
  • Market Cap
  • XENE 2.9B
  • HP 2.4B
  • IPO Year
  • XENE 2014
  • HP N/A
  • Fundamental
  • Price
  • XENE $42.30
  • HP $26.58
  • Analyst Decision
  • XENE Strong Buy
  • HP Hold
  • Analyst Count
  • XENE 10
  • HP 12
  • Target Price
  • XENE $53.00
  • HP $23.55
  • AVG Volume (30 Days)
  • XENE 742.2K
  • HP 1.4M
  • Earning Date
  • XENE 11-03-2025
  • HP 11-17-2025
  • Dividend Yield
  • XENE N/A
  • HP 3.76%
  • EPS Growth
  • XENE N/A
  • HP N/A
  • EPS
  • XENE N/A
  • HP N/A
  • Revenue
  • XENE $7,500,000.00
  • HP $3,428,058,000.00
  • Revenue This Year
  • XENE N/A
  • HP $38.43
  • Revenue Next Year
  • XENE $207.88
  • HP $3.25
  • P/E Ratio
  • XENE N/A
  • HP N/A
  • Revenue Growth
  • XENE N/A
  • HP 25.92
  • 52 Week Low
  • XENE $26.74
  • HP $14.65
  • 52 Week High
  • XENE $46.00
  • HP $37.46
  • Technical
  • Relative Strength Index (RSI)
  • XENE 59.76
  • HP 73.44
  • Support Level
  • XENE $40.79
  • HP $24.61
  • Resistance Level
  • XENE $43.33
  • HP $26.00
  • Average True Range (ATR)
  • XENE 1.59
  • HP 0.90
  • MACD
  • XENE -0.05
  • HP 0.18
  • Stochastic Oscillator
  • XENE 60.49
  • HP 97.58

About XENE Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.

About HP Helmerich & Payne Inc.

Helmerich & Payne Inc provides performance-driven drilling solutions and technologies that are intended to make hydrocarbon recovery safer and more economical for oil and gas exploration and production companies. The Company focus on the drilling segment of the oil and gas production value chain. Company operates in North America, Gulf of Mexico, and other international places such as Argentina, Australia, Bahrain, Colombia and the United Arab Emirates (UAE). Also own and operates a limited number of commercial real estate properties located in Tulsa, Oklahoma. It's real estate investments include a shopping center and of undeveloped real estate projects.

Share on Social Networks: